▶ 調査レポート

臨床検査管理システムの世界市場:導入モード別(Webベース、オンプレミス、クラウドベース)、コンポーネント別(ソフトウェア、ハードウェア、サービス)、エンドユーザー別、システムタイプ別、地域別分析

• 英文タイトル:Global Clinical Trial Management System Market - Segmented by Delivery Mode, Components, End User, System, and Geography - Growth, Trends, and Forecast (2018 - 2023)

Mordor Intelligenceが調査・発行した産業分析レポートです。臨床検査管理システムの世界市場:導入モード別(Webベース、オンプレミス、クラウドベース)、コンポーネント別(ソフトウェア、ハードウェア、サービス)、エンドユーザー別、システムタイプ別、地域別分析 / Global Clinical Trial Management System Market - Segmented by Delivery Mode, Components, End User, System, and Geography - Growth, Trends, and Forecast (2018 - 2023) / B-MOR-08120資料のイメージです。• レポートコード:B-MOR-08120
• 出版社/出版日:Mordor Intelligence / 2018年5月1日
• レポート形態:英文、PDF、112ページ
• 納品方法:Eメール(受注後2営業日)
• 産業分類:Healthcare
• 販売価格(消費税別)
  Single User(1名様用)¥454,750 (USD4,250)▷ お問い合わせ
  Team User(7名様用)¥481,500 (USD4,500)▷ お問い合わせ
  Corporate User¥936,250 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、臨床検査管理システムの世界市場について調べ、臨床検査管理システムの世界規模、市場動向、市場環境、導入モード別(Webベース、オンプレミス、クラウドベース)分析、コンポーネント別(ソフトウェア、ハードウェア、サービス)分析、エンドユーザー別分析、システムタイプ別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。
・イントロダクション
・エグゼクティブサマリー
・臨床検査管理システムの世界市場インサイト
・臨床検査管理システムの世界市場環境
・臨床検査管理システムの世界市場動向
・臨床検査管理システムの世界市場規模
・臨床検査管理システムの世界市場規模:導入モード別(Webベース、オンプレミス、クラウドベース)
・臨床検査管理システムの世界市場規模:コンポーネント別(ソフトウェア、ハードウェア、サービス)
・臨床検査管理システムの世界市場規模:エンドユーザー別
・臨床検査管理システムの世界市場規模:システムタイプ別
・臨床検査管理システムの世界市場:地域別市場規模・分析
・臨床検査管理システムの北米市場規模・予測
・臨床検査管理システムのアメリカ市場規模・予測
・臨床検査管理システムのヨーロッパ市場規模・予測
・臨床検査管理システムのアジア市場規模・予測
・臨床検査管理システムの日本市場規模・予測
・臨床検査管理システムの中国市場規模・予測
・臨床検査管理システムのインド市場規模・予測
・臨床検査管理システムの韓国市場規模・予測
・関連企業情報・競争状況

The global clinical trial management system market is expected to register a CAGR of 12.5% during the forecast period of 2018–2023. Clinical trial management system (CTMS) is a software solution for managing a large amount of clinical data in medical research, primarily conducted by pharmaceutical and biotechnological companies. With favorable government policies and support from different government funding bodies, North America is expected to dominate the market in the forecast period.

Growing Chronic Diseases and Lifestyle-Related Disorders

The growing prevalence of chronic diseases and lifestyle-related disorders is one of the major factors for the growth of CTMS market. Globally, chronic diseases kill more than 38 million people each year. It is primarily related to cardiovascular diseases, cancer, respiratory diseases, and diabetes. Consequently, this demands more new drugs, devices, and procedures to be developed and reach the market. Thus, increasing the demand for a large number of clinical trials in collaboration with universities and private companies in multiple regions. The surging demand for CTMS for proper management of clinical trials is driving the market.
Other factors, such as a rise in the outsourcing of the clinical trials and implementation by contract research organization (CRO) and increasing number of hospital chains synchronizing the hospital information system (HIS) with CTMS are driving the market.

Concerns Related to Data Security

The confidentiality of data related to a company’s device in a clinical trial or a patient’s information in healthcare is required both online, as well as, offline. With technological advancement, the risk of privacy and security of the records also increases, which is one of the major hindrances to this market. The organizations are hit by the lack of transparency affecting their overall quality and cost, which affects the patients. Other factors such as high cost associated with CTMS and lack of qualified and skilled labor to handle CTMS also hamper the growth of this market.

North America to Dominate the Market

North America is expected to dominate this market in the forecast period due to favorable government initiatives, including support from government bodies such as NCI, FDA, and NIH. Moreover, raising awareness among people regarding diseases increases their participation in clinical trials. Asia-Pacific is also expected to grow tremendously during the forecast period owing to factors, such as huge, diverse patient pool, outsourcing of clinical trials to CROs, and rising healthcare facilities in the region.

Key Developments in the Market

• January 2018: ERT Clinical showcased Voice Assistant Data Capture Solution, which improved the patient data management in clinical trials through simplified patient data collection.
• November 2017: Bioclinica launched Bioclinica Clinical Adjudication enabling the independent adjudication of clinical events.

Major players: BIOCLINICA, BIO-OPTRONICS, INC., DATATRAK INTERNATIONAL, INC., ERT CLINICAL, IBM WATSON HEALTH, MEDIDATA SOLUTIONS, INC., MEDNET SOLUTIONS, INC., ORACLE CORPORATION, PAREXEL INTERNATIONAL CORPORATION, AND SPARTA SYSTEMS, INC., amongst others.

Reasons to Purchase the Report

• A look at the current and future of the global clinical trial management system market in the developed and emerging regions.
• Analyzing various perspectives of the market with the help of Porter’s Five Forces Analysis.
• Identify the segment that is expected to dominate the market.
• Identify the regions that are expected to witness the fastest growth during the forecast period.
• Identify the latest developments, market shares, and strategies employed by the major market players.
• 3 months analyst support along with the Market Estimate sheet (in Excel).

Customization of the Report

• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.

レポート目次

1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Drivers
6.1.1 Rising Incidences of Chronic Diseases and Lifestyle-Related Disorders
6.1.2 Rise in Outsourcing of Clinical Trials and Implementation by Contract Research Organizations
6.1.3 Synchronization of Hospital Information System (HIS) with CTMS
6.2 Restraints
6.2.1 Data Security Issues
6.2.2 High Cost Associated with CTMS
6.2.3 Lack of Qualified and Skilled Labor to Handle CTMS
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Delivery Mode
7.1.1 Web-based Clinical Trial Management System
7.1.2 On-premise Clinical Trial Management System
7.1.3 Cloud-based Clinical Trial Management System
7.2 By Components
7.2.1 Software
7.2.2 Hardware
7.2.3 Services
7.3 By End User
7.3.1 Pharmaceuticals
7.3.2 Clinical Research Organization
7.3.3 Healthcare Providers
7.4 By Type of System
7.4.1 Site-based Clinical Trial Management System
7.4.2 Licensed Enterprise-based Clinical Trial Management System
7.5 By Geography
7.5.1 North America
7.5.1.1 United States
7.5.1.2 Canada
7.5.1.3 Mexico
7.5.1.4 Rest of North America
7.5.2 Europe
7.5.2.1 France
7.5.2.2 Germany
7.5.2.3 United Kingdom
7.5.2.4 Italy
7.5.2.5 Spain
7.5.2.6 Rest of Europe
7.5.3 Asia-Pacific
7.5.3.1 China
7.5.3.2 Japan
7.5.3.3 India
7.5.3.4 Australia
7.5.3.5 South Korea
7.5.3.6 Rest of Asia-Pacific
7.5.4 Middle East & Africa
7.5.4.1 GCC
7.5.4.2 South Africa
7.5.4.3 Rest of the Middle East & Africa
7.5.5 South America
7.5.5.1 Brazil
7.5.5.2 Argentina
7.5.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Bioclinica
9.2 Bio-Optronics, Inc.
9.3 DATATRAK International, Inc.
9.4 ERT Clinical
9.5 IBM Watson Health
9.6 Medidata Solutions, Inc.
9.7 MedNet Solutions, Inc.
9.8 Oracle Corporation
9.9 Parexel International Corporation
9.10 Sparta Systems, Inc.
9.11 List not Exhaustive
10. Future of the Market